Structure Therapeutics, Inc. Sponsored ADR's market cap is currently $1.30B. The company's EPS TTM is $-2.214; its P/E ratio is ―; Structure Therapeutics, Inc. Sponsored ADR is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.22. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -949.17K	$ -623.26K	$ -266.35K	$ -20.03K
Operating Income	$ -102.78M	$ -52.56M	$ -37.70K	$ -15.91K
EBITDA	$ -102.46M	$ -52.28M	$ -37.62M	$ -15.75M
Net Income	$ -89.62M	$ -51.32M	$ -38.05K	$ -15.88K
Balance Sheet
Cash & Short-Term Investments	$ 467.32M	$ 90.84M	$ 107.31K	$ 37.45K
Total Assets	$ 482.02M	$ 97.84M	$ 111.16K	$ 38.70K
Total Debt	$ 5.45M	$ 260.00K	$ 621.00	$ 280.00
Net Debt	$ -124.34M	$ -90.58M	$ -104.68K	$ -16.07K
Total Liabilities	$ 29.05M	$ 212.99M	$ 175.89K	$ 61.17K
Stockholders' Equity	$ 452.97M	$ -115.14M	$ -64.73K	$ -22.47K
Cash Flow
Free Cash Flow	$ -81.66M	$ -46.27M	$ -33.37K	$ -14.30K
Operating Cash Flow	$ -79.49M	$ -46.12M	$ -32.16K	$ -14.28K
Investing Cash Flow	$ -268.34M	$ -62.11M	$ 17.86K	$ -21.15K
Financing Cash Flow	$ 451.53M	$ 29.01M	$ 103.25K	$ 25.84K

Currency in USD

Structure Therapeutics, Inc. Sponsored ADR Earnings and Revenue History

Income Statement >

Structure Therapeutics, Inc. Sponsored ADR Debt to Assets

Balance Sheet >

Structure Therapeutics, Inc. Sponsored ADR Cash Flow

Cash Flow >

Structure Therapeutics, Inc. Sponsored ADR Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing